Eli Lilly violates patients' privacy

被引:1
|
作者
Yamey, G
机构
来源
BRITISH MEDICAL JOURNAL | 2001年 / 323卷 / 7304期
关键词
D O I
10.1136/bmj.323.7304.65/a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:65 / 65
页数:1
相关论文
共 50 条
  • [21] GLAXO EYES ELI-LILLY BID
    不详
    EUROPEAN CHEMICAL NEWS, 1994, 62 (1632): : 4 - 4
  • [22] OPEN PLAN WORKS AT ELI-LILLY
    不详
    ADMINISTRATIVE MANAGEMENT, 1970, 31 (03): : 46 - &
  • [23] Eli Lilly announces restructuring, job cuts
    不详
    EJHP PRACTICE, 2009, 15 (05): : 14 - 14
  • [24] FDA approves Eli Lilly's baricitinib
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (07) : 460 - 460
  • [25] CEFACLOR (CECLOR - ELI-LILLY-AND-COMPANY)
    BERGMAN, HD
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (01): : 11 - 16
  • [26] WASTE DISPOSAL BY PULPING AT ELI LILLY AND COMPANY
    YOKE, WR
    MECHANICAL ENGINEERING, 1967, 89 (06) : 77 - &
  • [27] Eli Lilly and Company Insulins A Century of Innovation
    Malone, J. K.
    Anderson, J. H.
    Wolpert, H. A.
    Ilag, L. L.
    Frank, B. H.
    De Felippis, M. R.
    Paavola, C. D.
    Orr, A. L.
    Beals, J. M.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2020, 17 : 138 - 160
  • [28] The History of Flow Chemistry at Eli Lilly and Company
    Johnson, Martin D.
    Braden, Timothy
    Calvin, Joel R.
    Brewer, Alison Campbell
    Cole, Kevin P.
    Frank, Scott
    Kerr, Mark
    Kjell, Doug
    Kopach, Michael E.
    Martinelli, Joseph R.
    May, Scott A.
    Rincon, Juan
    White, Timothy D.
    Yates, Matthew H.
    CHIMIA, 2023, 77 (05) : 319 - 326
  • [29] Eli Lilly - DNA patenting through the ages
    Burke, JF
    Thomas, SM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (02) : 119 - 127
  • [30] Eli Lilly enters venture capital arena
    Liz Fletcher
    Nature Biotechnology, 2001, 19 : 997 - 998